Melatonin, circadian rhythms, and sleep

Opinion statementExperimental data show a close relationship among melatonin, circadian rhythms, and sleep. Low-dose melatonin treatment, increasing circulating melatonin levels to those normally observed at night, promotes sleep onset and sleep maintenance without changing sleep architecture. Melatonin treatment can also advance or delay the phase of the circadian clock if administered in the evening or in the morning, respectively. If used in physiologic doses and at appropriate times, melatonin can be helpful for those suffering from insomnia or circadian rhythm disorders. This may be especially beneficial for individuals with low melatonin production, which is established by measuring individual blood or saliva melatonin levels. However, high melatonin doses (over 0.3 mg) may cause side effects and disrupt the delicate mechanism of the circadian system, dissociating mutually dependent circadian body rhythms. A misleading labeling of the hormone melatonin as a “food supplement” and lack of quality control over melatonin preparations on the market continue to be of serious concern.

[1]  E. Palazidou,et al.  An alpha2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man , 2004, Psychopharmacology.

[2]  W. O'steen,et al.  Melatonin increases photoreceptor susceptibility to light-induced damage. , 1992, Investigative ophthalmology & visual science.

[3]  R. Wurtman,et al.  Effects of a Low Dose of Melatonin on Sleep in Children with Angelman Syndrome , 1999, Journal of pediatric endocrinology & metabolism : JPEM.

[4]  P. Lavie,et al.  The Association between the Nocturnal Sleep Gate and Nocturnal Onset of Urinary 6-Sulfatoxymelatonin , 1993, Journal of biological rhythms.

[5]  M. L. Pires,et al.  Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin , 2001, Brain Research.

[6]  A. Lewy,et al.  The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. , 1998, Sleep.

[7]  J. Röschke,et al.  Increased bioavailability of oral melatonin after fluvoxamine coadministration , 2000, Clinical pharmacology and therapeutics.

[8]  E. Monrós,et al.  [Angelman syndrome: physical characteristics and behavioural phenotype in 37 patients with confirmed genetic diagnosis]. , 2002, Revista de neurologia.

[9]  T. Nickelsen,et al.  Influence of Dexamethasone on Nocturnal Melatonin Production in Healthy Adult Subjects , 1988, Journal of pineal research.

[10]  C. Thompson,et al.  Effect of Fluoxetine on Melatonin in Patients with Seasonal Affective Disorder and Matched Controls , 1995, British Journal of Psychiatry.

[11]  B. Stone,et al.  Hypnotic activity of melatonin. , 2000, Sleep.

[12]  R. Wurtman,et al.  Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  I. Zhdanova,et al.  Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans , 2000, Pharmacology Biochemistry and Behavior.

[14]  J. Taylor,et al.  Melatonin treatment for age-related insomnia. , 2001, The Journal of clinical endocrinology and metabolism.

[15]  R. Wurtman,et al.  Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans. , 1996, Sleep.

[16]  L. Ferini-Strambi,et al.  Effect of melatonin on sleep microstructure: preliminary results in healthy subjects. , 1993, Sleep.

[17]  P. Lercher,et al.  Influence of beta-blockers on melatonin release , 1999, European Journal of Clinical Pharmacology.

[18]  B. Middleton,et al.  Complex Effects of Melatonin on Human Circadian Rhythms in Constant Dim Light , 1997, Journal of biological rhythms.

[19]  J R Ives,et al.  Sleep‐inducing effects of low doses of melatonin ingested in the evening , 1995, Clinical pharmacology and therapeutics.